Hidetaka Matsumoto Selected Research

Hidetaka Matsumoto Research Topics

15	Macular Degeneration (Age-Related Maculopathy) 01/2024 - 01/2017
12	Polypoidal Choroidal Vasculopathy 01/2024 - 01/2010
7	Inflammation (Inflammations) 01/2024 - 01/2016
5	Retinal Detachment (Retinal Detachments) 01/2019 - 09/2013
4	Central Serous Chorioretinopathy 11/2023 - 01/2018
3	Choroidal Neovascularization 03/2023 - 01/2018
3	Atrophy 01/2023 - 12/2016
2	Retinal Vasculitis 11/2023 - 01/2023
2	Pathologic Constriction (Stenosis) 08/2022 - 01/2021
1	Cardiac Arrhythmias (Arrythmia) 08/2022
1	Thromboembolism 08/2022
1	Disease Progression 01/2022
1	Carotid-Cavernous Sinus Fistula 01/2022
1	Papilledema 02/2021
1	Macular Edema 02/2021
1	Epiretinal Membrane (Epiretinal Membranes) 02/2021
1	Melanoma (Melanoma, Malignant) 01/2019
1	Hypoxia (Hypoxemia) 10/2018
1	Eye Diseases (Eye Disease) 01/2016
1	Vision Disorders (Hemeralopia) 07/2015
1	Hemorrhage 07/2013
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 09/2012
1	Retinal Degeneration 09/2012
1	Retinitis 09/2012

11	afliberceptIBA 01/2023 - 12/2016
9	brolucizumabIBA 01/2024 - 01/2021
6	Retinaldehyde (Retinal)IBA 11/2023 - 07/2015
6	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2023 - 01/2010
4	SteroidsIBA 01/2022 - 07/2018
3	Hyaluronic Acid (Hyaluronan)IBA 10/2018 - 09/2013
2	faricimabIBA 01/2024 - 10/2023
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2022 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2021 - 01/2017
2	Ranibizumab (Lucentis)FDA Link 01/2017 - 07/2013
1	Phenobarbital (Luminal)FDA Link 01/2022
1	IpilimumabIBA 01/2019
1	NivolumabIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Interferon-betaIBA 01/2019
1	Dacarbazine (DIC)FDA LinkGeneric 01/2019
1	NimustineIBA 01/2019
1	Vincristine (Oncovin)FDA LinkGeneric 01/2019
1	CytokinesIBA 10/2018
1	Ion Channels (Ion Channel)IBA 10/2018
1	polyethylene glycol-poly(lactide-co-glycolide)IBA 01/2016
1	AMP-Activated Protein KinasesIBA 01/2016
1	Phosphotransferases (Kinase)IBA 09/2012
1	Receptor-Interacting Protein Serine-Threonine KinasesIBA 09/2012
1	Verteporfin (Visudyne)FDA Link 06/2010
1	Bevacizumab (Avastin)FDA Link 06/2010

9	Therapeutics 01/2024 - 06/2010
6	Photochemotherapy (Photodynamic Therapy) 11/2023 - 06/2010
5	Injections 01/2023 - 07/2013
4	Intravitreal Injections 11/2023 - 01/2017
1	Lasers (Laser) 03/2023
1	Light Coagulation 03/2023
1	Traction 02/2021
1	Vitrectomy 02/2021
1	Aftercare (After-Treatment) 01/2021
1	Retreatment 06/2010